- Home
- NIKI vs BDRX Comparison
NIKI vs BDRX Comparison
Compare NIKI & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NIKI | BDRX |
|---|---|---|
| Founded | 2010 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.6M |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | NIKI | BDRX |
|---|---|---|
| Price | $1.87 | $3.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.7K | ★ 1.0M |
| Earning Date | 11-10-2026 | 09-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $48.88 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.78 | $0.34 |
| 52 Week High | $10.39 | $8.94 |
Technical Indicators
Market Signals| Indicator | NIKI | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 22.57 | 82.72 |
| Support Level | N/A | $2.97 |
| Resistance Level | $5.17 | $4.39 |
| Average True Range (ATR) | 0.35 | 0.19 |
| MACD | 0.05 | 0.45 |
| Stochastic Oscillator | 8.54 | 88.67 |
Price Performance
Historical ComparisonAbout NIKI Niki BioSolutions Inc. Common Stock
Niki BioSolutions Inc is a clinical-stage life sciences company focused on unmet medical needs and providing genomic and biomarker testing solutions to healthcare providers, research institutions, and life sciences organizations. Its activities include the development and application of proprietary technologies to support precision medicine across therapeutic areas including brain health and oncology. The company also collaborates with academic centers, disease foundations, and biopharmaceutical companies.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.